Clinical Trials Directory

Trials / Terminated

TerminatedNCT04206501

OptiVol for Precision Medical Management of Heart Failure

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This clinical study is designed to show that a multidisciplinary team following a pre-specified standard of care medication decision model based on data from an implanted cardioverter device will increase the rate of change in Guideline Directed Medical Therapy (GDMT) in the intervention group compared to the conventional group in patients with ischemic and non-ischemic cardiomyopathies.

Detailed description

Subjects in this study will be randomized (2:1) to an intervention group whose medical care will be guided by data from a cardiac implantable electronic device (CIED) including information on heart rate, activity, and fluid status derived from the OptiVol monitor versus a conventional management control group. Subjects will followed for 12 months with follow up contact for 6 consecutive months and a chart review at 12 months. The study population will include patients with ischemic and non-ischemic cardiomyopathy who have had an ICD implanted per standard of care guidelines.

Conditions

Interventions

TypeNameDescription
DEVICEMedtronic ICD with Opti Vol-MonitorPhysiologic and functional data from Cardiac Implantable Electronic Devices (CIEDs), including information on heart rate, activity, and fluid status derived from the OptiVol monitor, together with a concurrent patient engagement strategy through remote interactions, can be used to optimize the medical management of HF patients implanted with an ICD.

Timeline

Start date
2020-02-05
Primary completion
2022-11-01
Completion
2022-11-20
First posted
2019-12-20
Last updated
2025-06-06
Results posted
2025-06-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04206501. Inclusion in this directory is not an endorsement.